Articles by Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA
Dr. Dickinson discusses major updates to be presented during the 2023 European Hematology Association Congress.
Dr. Dickinson and colleagues presented the research at the 2023 American Society of Clinical Oncology Annual Meeting.
Dr. Dickinson discusses what he sees as the key highlights in lymphoma research during the summer 2023 conference season.
Michael Dickinson, MBBS, DMedSc, discusses trials in progress that are evaluating glofitamab with other agents for DLBCL.
Michael Dickinson, MBBS, DMedSc, discusses a phase II trial of glofitamab, a bispecific antibody, in patients with DLBCL.
Michael Dickinson, MBBS, DMedSc, discusses updates on glofitamab that were presented during the 2022 ASH meeting.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.